Page last updated: 2024-08-21

n-methylpyrrolidone and Atherogenesis

n-methylpyrrolidone has been researched along with Atherogenesis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Andres, V; Bernal, JA; Cruz, FM; Gewert, D; Gonzalez-Guerra, A; Hardwick, B; Ibanez, B; Mckenzie, G; Palma, JA; Roche-Molina, M; Sanchez-Ramos, C; Sanz-Rosa, D	1

Other Studies

1 other study(ies) available for n-methylpyrrolidone and Atherogenesis

Article	Year
The pharmaceutical solvent N-methyl-2-pyrollidone (NMP) attenuates inflammation through Krüppel-like factor 2 activation to reduce atherogenesis. Scientific reports, 2020, 07-15, Volume: 10, Issue:1 Topics: Animals; Anti-Inflammatory Agents; Aorta; Apoptosis; Atherosclerosis; Cell Adhesion; Cell Line; DNA, Complementary; Endothelial Cells; Gene Expression Profiling; Gene Library; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Kruppel-Like Transcription Factors; Mice; Mice, Knockout, ApoE; Monocytes; Pyrrolidinones; RNA, Small Interfering; Solvents; Tumor Necrosis Factor-alpha	2020

Article

Year

The pharmaceutical solvent N-methyl-2-pyrollidone (NMP) attenuates inflammation through Krüppel-like factor 2 activation to reduce atherogenesis.

Scientific reports, 2020, 07-15, Volume: 10, Issue:1

Topics: Animals; Anti-Inflammatory Agents; Aorta; Apoptosis; Atherosclerosis; Cell Adhesion; Cell Line; DNA, Complementary; Endothelial Cells; Gene Expression Profiling; Gene Library; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Kruppel-Like Transcription Factors; Mice; Mice, Knockout, ApoE; Monocytes; Pyrrolidinones; RNA, Small Interfering; Solvents; Tumor Necrosis Factor-alpha

2020